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H elicobacter pylori is the major cause of gastric cancer [1 , 2],  which usually occurs in older 
patients.  Some studies have revealed that 2.7-15% of 
patients with gastric cancer are young age [3-8].  Several 
studies have reported the clinicopathological features 
and prognosis of gastric cancer in young patients.  
Gastric cancer in young patients is reportedly associated 
with an increased prevalence of women and cases of 
diffuse type,  poorly differentiated lesions,  lymph node 
metastasis,  and a poor prognosis due to a diagnosis at 
an advanced stage [9].  However,  since most studies 
have been retrospective case-control studies with small 
sample sizes,  the clinicopathological features of gastric 
cancer in young patients remain unclear.
Global gastric cancer incidence and mortality rates 
have been declining over the last five decades world-
wide,  due in part to the eradication of H. pylori infec-
tion,  medical screening,  and advances in treatment 
[10].  However,  a stable or even slightly increasing 
trend of gastric cancer in young adults has been 
reported [11].  Therefore,  it is important to discuss the 
clinical problems of gastric cancer in young patients at 
present.
In this review,  we summarize the current under-
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Gastric cancer usually arises in middle-aged to older patients,  and is rarely found in younger patients.  The clin-
ical characteristics,  etiology,  prognosis,  preventive methods and treatment of gastric cancer in young patients 
have not been fully investigated because of its low prevalence.  In this review,  we discuss the current under-
standing and clinical problems associated with gastric cancer in young patients.  Helicobacter pylori (H. pylori),  
which is a major cause of gastric cancer,  especially in older populations,  is closely associated with gastric cancer 
in young patients as well as in older patients.  Gastric cancer in young patients tends to be diagnosed at an 
advanced stage with alarm symptoms.  However,  young patients with advanced gastric cancer tend to have a 
favorable general condition and organ function,  so they can tolerate intensive systematic chemotherapy.  
Unfortunately,  the prognosis of gastric cancer in young patients with an advanced stage is not favorable.  We 
should not take this rare disease lightly,  given its poor prognosis if patients are diagnosed at an unresectable 
stage.  The evaluation of the H. pylori infection status and performance of H. pylori eradication therapy to prevent 
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standing and clinical problems associated with gastric 
cancer in young patients.
Definition and Clinicopathological Features of 
Gastric Cancer in Young Patients
The definitions of gastric cancer in young patients 
have differed among studies.  In some studies,  gastric 
cancer in young patients is defined as that manifesting 
before 40 years old,  while in others,  the definition gen-
erally includes all patients diagnosed before 45 years 
old.  For this reason,  the reported clinicopathological 
features of gastric cancer in young patients are varied.  
Approximately 10% of gastric cancer patients report-
edly fall into the “gastric cancer in young patients” cate-
gory [12].
Before 40 years old,  the incidence of gastric cancer 
is higher in women than in men,  while in those older 
than 40 years old,  the incidence of gastric cancer 
increases dramatically in men [5 , 8 , 13-15].  This higher 
female proportion suggents that sex hormones,  espe-
cially estrogen,  may play an important role in the 
development of gastric cancer in young patients 
[16 , 17].  In addition,  gastric cancer in young patients 
has a more aggressive growth pattern than that in old 
patients.  The predominance of a poorly differentiated 
histological type,  diffuse macroscopic type,  advanced 
tumor stage,  lymphovascular invasion,  and high 
non-curability rate are all poor prognostic factors for 
gastric cancer in young patients [13 , 15 , 18-22].  An 
increased frequency of bone metastases in gastric can-
cer in young patients may also be associated with estro-
gen receptor positivity,  as has been demonstrated in 
other cancer types [8 , 23].
In general,  gastric cancer develops through a cas-
cade of well-defined and recognizable steps — inflam-
mation,  atrophy,  intestinal metaplasia,  dysplasia,  and 
carcinogenesis — and is closely associated with the envi-
ronment,  diet,  and gene mutations [24-27].  Genetic 
factors may be more important in gastric cancer in 
young patients than in older patients,  as younger 
patients have less exposure to environmental carcino-
gens [28 , 29].  Familial clustering was found in 10% of 
gastric cancer cases,  and epidemiological studies have 
demonstrated that the risk of gastric cancer in first- 
degree relatives is increased 2- to 3-fold [30].  Early-
onset gastric cancer can arise in such populations.  
Furthermore,  hereditary diffuse gastric cancer (HDGC),  
Lynch syndrome,  juvenile polyposis syndrome (JPS),  
Peutz-Jeghers syndrome (PJS),  familial adenomatous 
polyposis,  and other less common hereditary cancer 
predisposition syndromes should be discussed as differ-
ential diagnoses in cases of gastric cancer in young 
patients.
The comprehensive molecular analyses of gastric 
cancer,  including The Cancer Genome Atlas (TCGA),  
suggested 4 molecular subtypes: tumors positive for 
Epstein- Barr virus (EBV),  microsatellite instability 
(MSI),  genomically stable (GS),  and chromosomal 
instability (CIN) [31].  We will discuss the relationship 
between these subtypes and gastric cancer in young 
patients.  Among these subtypes,  GS subtype tumors 
tend to be related to an early onset and diffuse-type his-
tology.  Microsatellite instability-high (MSI-H) tumors 
are enriched in older patients,  while the microsatellite 
stable/epithelial-mesenchymal transition subtype pres-
ents at a significantly younger age,  with most patients 
diagnosed at an advanced stage [32 , 33].  Regarding the 
EBV,  a meta-analysis found that the overall prevalence 
of EBV positivity in gastric cancer was estimated to be 
8.7% [34].  EBV has been implicated in gastric carcino-
genesis,  and its positivity is slightly more frequent in 
diffuse-type gastric cancers than in intestinal-type gas-
tric cancers [35-37].  A previous study indicated that 
gastric cancer in young patients was characterized by 
both EBV positivity as well as enhanced immunostain-
ing of PD-L1,  suggesting that such patients may candi-
dates for immunotherapy [38].
Contribution of H. pylori Infection to the  
Pathogenesis of Gastric Cancer  
in Young Patients
Since the incidence of H. pylori infection is lower in 
heathy young adults than in older individuals,  the con-
tribution of H. pylori infection to the pathogenesis of 
gastric cancer in young patients has been considered 
small.  With the spread of H. pylori eradication therapy,  
the morbidity rate of gastric cancer in young patients is 
decreasing in Japan.  H. pylori infection usually takes 
several decades to induce histological changes and sub-
sequent neoplastic transformation.  Indeed,  it has been 
reported that gastric cancer in young patients is related 
to less intestinal metaplasia [39 , 40],  which suggests 
that different mechanisms of H. pylori can induce car-
cinogenesis in younger populations.
Table 1 shows studies that reported the incidence of 
H. pylori infection in young patients with gastric cancer.  
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The incidence ranges from 23.9% to 88% in studies 
from various countries [6 , 21 , 22 , 38 , 40-46].  This vari-
ation of incidence is due to not only to the regions of the 
studies but also the number of patients whose H. pylori 
infection status was assessed.  Given the low incidence 
of H. pylori infection in the healthy Japanese population 
[47],  the higher incidence of H. pylori infection is 
revealed.  This indicates that H. pylori infection plays an 
important role in the development of gastric cancer in 
young patients as well as older patients [37 , 48 , 49].
H. pylori infection is usually related to the pathogen-
esis of differentiated-type gastric cancer [50 , 51],  while 
most cases of gastric cancer in young patients are undif-
ferentiated-type gastric cancer.  This may seem para-
doxical.  The inflammation induced by H. pylori infec-
tion reportedly promotes the development of 
undifferentiated-type gastric cancer [52].  Hirahashi et 
al.  even found a significantly higher incidence of H. 
pylori infection among the young patients than among 
older patients with intramucosal cancer of poorly dif-
ferentiated type [49 , 53].  Observational studies of 
Japanese adults with nodular gastritis,  which is closely 
related to active inflammation by H. pylori infection,  
have suggested an association with gastric cancer,  par-
ticularly diffuse type gastric cancer [54 , 55].  These 
studies support our hypothesis in this review that H. 
pylori infection can induce active gastritis,  and carcino-
genesis and promote the rapid progression of undiffer-
entiated-type gastric cancer in young patients.
The Prognosis of Gastric Cancer in Young 
Patients Compared to Older Patients
While some studies have demonstrated poor out-
comes of gastric cancer in young patients,  others have 
reported a better prognosis than in older individuals,  
and some still have described no marked differences in 
the survival based on age.  Table 2 compares the prog-
nosis of gastric cancer in young versus older patients.  
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Table 1　 Incidence of Helicobacter pylori infection in young 
patients with gastric cancer
Author (year) Country n Patient age Incidence (%)
Kokkola
(1996) [12] Finland 50 ≤45 72
Chung
(2010) [6] Korea 1,584 31-40 23.9
Nam
(2011) [41] Korea 185 ≤40 80.5
Marcos
(2013) [42] Portugal 103 ≤45 82
Pisanu
(2014) [44] Italy 20 <50 25
Bautista
(2014) [43] USA 34 <40 88
Zhou F
(2016) [21] China 152 <40 51.1
Lee
(2016) [45] Korea 57 <40 65
Ji
(2017) [22] China 45 <40 75.6
Kono
(2019) [46] Japan 67 <40 81
Moore
(2020) [38] Israel 39 ≤45 36
Table 2　 The prognosis of young patients with gastric cancer compared to older patients
Author
(year) Country Study design Subject (age,  years old) Median OS (months)
Nakamura
(2011) [18] Japan Retrospective
All stage




















≤40 (n=71) vs. 41-65 (n=129) 15 vs. 21
Takesin
(2019) [58] Turkey Retrospective
All stage






≤45 (n=39) vs. ≧55 (n=35) 69.7 vs. 47.8
OS,  overall survival.
The subjects of these studies had disease of all stages,  
and we excluded the studies including only gastric can-
cer patients after surgical resection.  Although gastric 
cancer in young patients has been reported to have 
aggressive clinicopathological factors,  most studies 
reported that the overall survival (OS) of gastric cancer 
in young patients was comparable to that in older 
patients.  However,  Nakamura et al.  and Rona et al.  
reported that the survival rate of gastric cancer in young 
patients was worse than that in older patients [18 , 56].  
Kono et al.  compared the OS in patients in their 20s 
with that in patients in their 30s,  concluding that the 
former was worse [46].  However,  the variation in the 
OS may be because patients in most studies were not 
matched based on tumor stage.  Gastric cancer in young 
patients has a better prognosis than that in older 
patients at an early stage [57 , 58] but a poor prognosis in 
the advanced stage [45 , 46].
The Early Diagnosis,  Prevention,  and 
Treatment for Gastric Cancer  
in Young Patients
Gastric cancer in young patients is most often diag-
nosed at the advanced stage with organ involvement,  
suggesting a potentially greater burden of disease,  which 
may lead to the poor long-term survival [8 , 56 , 59].  
Since a large proportion of cases of gastric cancer in 
young patients may have no alarm symptoms,  gastric 
cancer is not considered a differential diagnosis in 
young patients.  Indeed,  several studies investigated the 
relationship between symptoms and the disease status of 
gastric cancer in young patients,  finding that the pro-
portion of cases with alarm symptoms was significantly 
higher in the advanced stage than in the early stage 
[5 , 18 , 51].
The early diagnosis in gastric cancer in young 
patients may contribute to the long-term survival.  
However,  young populations are not indicated for 
endoscopic screening in various guidelines,  which can 
delay the investigation and diagnosis and result in a 
more advanced stage at detection [46 , 60].  Mass screen-
ing endoscopy has been introduced to detect early-stage 
gastric cancer in Korea and Japan,  where gastric cancer 
is prevalent.  However,  the screening targets are limited 
to individuals ≥ 40 years old because overuse of endos-
copy is associated with a low yield rate in young patients 
and is not cost-effective.  Furthermore,  young patients 
tend to avoid promptly visiting the hospital when they 
have symptoms,  which can delay the diagnosis.
Another important issues to consider is how to get 
young populations to avoid risk factors.  A systemic 
review and meta-analysis showed that the eradication of 
H. pylori in asymptomatic,  infected adults led to a 
reduced incidence of gastric cancer [61 , 62].  Unfor-
tunately,  the system,  efficacy,  and safety of H. pylori 
eradication for the prevention of gastric cancer in young 
patients has not been established.  To screen for high-
risk young patients with gastric cancer,  a system for 
checking the H. pylori infection status,  and evaluating 
the family history of gastric cancer in young adults must 
be established.  Of course,  the prevention of H. pylori 
infection is more useful to reduce the incidence of gas-
tric cancer in young patients.  Since family infection 
such as the infection from mother to infant is the high-
est risk of H. pylori infection,  preventing H. pylori infec-
tion among the family is an important issue.  Checking 
and eradication of H. pylori should be performed before 
marriage and having infants.
When young patients with gastric cancer are diag-
nosed at the unresectable stage,  they undergo system-
atic chemotherapy.  Young patients who are diagnosed 
with gastric cancer at an advanced stage tend to have a 
better performance status than older patients [57 , 63].  
With a favorable general condition and organ function,  
young patients with advanced gastric cancer experience 
fewer adverse events than older patients,  which can 
facilitate intensive chemotherapy.  The efficacy and tol-
erance of systematic chemotherapy for gastric cancer in 
young patients has been reported [64].  Nevertheless,  
the survival of gastric cancer in young patients at the 
unresectable stage is not favorable,  ranging from 5-6 
months for the median OS [5 , 46].  More intensive anti-
cancer drugs for young patients with unresected gastric 
cancer are desired to improve the survival.
Conclusion
We reviewed the current understanding and clinical 
problems associated with gastric cancer in young 
patients.  While difficult,  diagnosis is necessary,  along 
with the development of novel preventive methods and 
intensive treatments for gastric cancer in young 
patients.  Although gastric cancer in young patients has 
a low prevalence and low mortality,  we should treat the 
clinical issues of gastric cancer in young patients seri-
ously,  due to its aggressive nature and miserable prog-
464 Kono et al. Acta Med.  Okayama　Vol.  74,  No.  6
nosis if diagnosed at the unresectable stage.
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